Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership217,925 shares
Latest Disclosed Value $ 7,084,741
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 2.98% increase in ownership of PCVX / Vaxcyte, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 217,925 shares of Vaxcyte, Inc. (US:PCVX) valued at $7,084,742 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 211,621 shares of Vaxcyte, Inc.. This represents a change in shares of 2.98% during the quarter. The current value of the position is $10,626,023 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Vaxcyte EC US92243G1085 217,925 6,304 2.98 7,085 -11.34 0.1591
2025-05-28 2025-03-31 NP Vaxcyte EC US92243G1085 211,621 2,247 1.07 7,991 -53.38 0.1917
2025-02-25 2024-12-31 NP Vaxcyte EC US92243G1085 209,374 -24,981 -10.66 17,139 -36.00 0.3743
2024-11-26 2024-09-30 NP Vaxcyte EC US92243G1085 234,355 33,352 16.59 26,780 76.44 0.5065
2024-08-26 2024-06-30 NP Vaxcyte EC US92243G1085 201,003 14,959 8.04 15,178 19.43 0.3091
2024-05-28 2024-03-31 NP Vaxcyte EC US92243G1085 186,044 15,243 8.92 12,709 18.48 0.2652
2024-02-26 2023-12-31 NP Vaxcyte EC US92243G1085 170,801 11,736 7.38 10,726 32.27 0.2289
2023-11-28 2023-09-30 NP Vaxcyte EC US92243G1085 159,065 265 0.17 8,109 2.26 0.2116
2023-08-25 2023-06-30 NP Vaxcyte EC US92243G1085 158,800 44,141 38.50 7,930 84.55 0.1881
2023-05-26 2023-03-31 NP Vaxcyte EC US92243G1085 114,659 2,110 1.87 4,297 -20.37 0.1144
2023-02-24 2022-12-31 NP Vaxcyte EC US92243G1085 112,549 29,127 34.92 5,397 169.53 0.1485
2022-11-25 2022-09-30 NP Vaxcyte EC US92243G1085 83,422 1,987 2.44 2,002 12.98 0.0574
2022-08-25 2022-06-30 NP Vaxcyte EC US92243G1085 81,435 18,540 29.48 1,772 16.73 0.0489
2022-05-26 2022-03-31 NP Vaxcyte EC US92243G1085 62,895 1,115 1.80 1,519 3.34 0.0354
2022-02-25 2021-12-31 NP Vaxcyte EC US92243G1085 61,780 1,928 3.22 1,470 -3.23 0.0319
2021-11-24 2021-09-30 NP Vaxcyte EC US92243G1085 59,852 0 0.00 1,518 12.69 0.0335
2021-08-26 2021-06-30 NP Vaxcyte EC US92243G1085 59,852 16,535 38.17 1,347 57.54 0.0289
2021-05-27 2021-03-31 NP Vaxcyte EC US92243G1085 43,317 13,776 46.63 856 9.06 0.0194
2021-02-25 2020-12-31 NP Vaxcyte EC US92243G1085 29,541 0 0.00 785 -46.23 0.0201
2020-11-25 2020-09-30 NP Vaxcyte EC US92243G1085 29,541 29,541 1,459 0.0468
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.